Gerlinde M. Michl

Statistics

Publications

Citations

907

H-Index

Active since

1998

Affiliations

Ludwig-Maximilians-Universität München(Current)

LMU Klinikum

Gerlinde M. Michl is an author at Ludwig-Maximilians-Universität München specializing in clinical pharmacology, antiretroviral therapy, and pharmacology.

Publications per year

1998–2001

Publications

Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients

Ravi Walli, Oliver Herfort, Gerlinde M. Michl et al. · AIDS · 1998 · 537 citations

Medicine, Pharmacotherapy, Clinical Nutrition +14

Stavudine Versus Zidovudine and the Development of Lipodystrophy

Johannes R. Bogner, Volker Vielhauer, R Beckmann et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 103 citations

Medicine, Pharmacology, Pharmacotherapy +13

Effects of troglitazone on insulin sensitivity in HIV-infected patients with protease inhibitor-associated diabetes mellitus

Ravi Walli, Gerlinde M. Michl, Dieter Mühlbayer et al. · Research in Experimental Medicine · 1999 · 70 citations

Medicine, Endocrinology, Pharmacology +14

Alterations of Apolipoprotein B Metabolism in HIV-Infected Patients With Antiretroviral Combination Therapy

Michaela Schmitz, Gerlinde M. Michl, Ravi Walli et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2001 · 61 citations

Life Sciences, Biochemistry, Pharmacology +13

Improvement of HAART-associated insulin resistance and dyslipidemia after replacement of protease inhibitors with abacavir.

R Walli, Gerlinde M. Michl, J R Bogner et al. · PubMed · 2001 · 53 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +12

1–5 of 7